ASPEN PHARMACARE HOLDINGS LIMITED - Appointment of Babalwa Ngonyama as Chairman of the Audit & Risk Committee
APN 201712110032A
Appointment of Babalwa Ngonyama as Chairman of the Audit & Risk Committee
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN ISIN: ZAE000066692
(“Aspen Holdings or the Company”)
Appointment of Babalwa Ngonyama as Chairman of the Audit & Risk Committee
The Board of Aspen is pleased to announce that it has appointed Ms Babalwa Ngonyama to
succeed Mr John Buchanan as the Chairman of the Company’s Audit & Risk Committee (“the
Committee”) with effect from 1 January 2018. Mr Buchanan, who has expressed his intention
to retire as a director of the Company during the 2018 calendar year, will remain a member of
this Committee.
The Board wishes to express its sincere appreciation for Mr Buchanan’s many years of
dedicated service to Aspen in his capacity as chairman of this Committee and wish
Ms Ngonyama all the best in this new role.
Durban
11 December 2017
Sponsor
Investec Bank Limited
Date: 11/12/2017 10:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
